MICS Centrum Medyczne Torun

Torun, Kuyavian-Pomeranian Voivodeship 87100

2 studies enrolling now · 7 studies all time

What they study most

Diabetic Peripheral Neuropathy, Lyme Disease, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Plaque Psoriasis, Rheumatoid Arthritis, SARS-CoV-2 Infection, COVID-19, Secondary Immune Deficiency

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain — Completed
• Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies — Starting soon
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children — Completed
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling